Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
11 hedge funds and large institutions have $7.85M invested in Zosano Pharma Corporation in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
21% less funds holding
Funds holding: 14 → 11 (-3)
44% less capital invested
Capital invested by funds: $13.9M → $7.85M (-$6.08M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$25.8K |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$14.2K |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
-$6K |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
-$2K |
| 5 |
Barclays
London,
United Kingdom
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NMC
1
NEA Management Company
Timonium,
Maryland
| $2.74M | – | – | – |
|
|
2
Fidelity Investments
Boston,
Massachusetts
| $2.34M | -$25.8K | -20 | -0.8% |
|
|
EAM
3
Eventide Asset Management
Boston,
Massachusetts
| $1.17M | – | – | – |
|
|
LOAMU
4
Lombard Odier Asset Management (USA)
New York
| $630K | – | – | – |
|
|
PI
5
Putnam Investments
Boston,
Massachusetts
| $528K | – | – | – |
|
|
SM
6
Sabby Management
Miami Beach,
Florida
| $170K | – | – | – |
|
|
VC
7
Vivo Capital
Palo Alto,
California
| $125K | – | – | – |
|
8
Vanguard Group
Malvern,
Pennsylvania
| $120K | – | – | – |
|
|
KCM
9
Knoll Capital Management
Miami,
Florida
| $15K | -$14.2K | -11 | -41% |
|
|
BFA
10
BlackRock Fund Advisors
San Francisco,
California
| $2K | – | – | – |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $1K | +$1.29K | +1 | +100% |
|
|
IA
12
IFP Advisors
Tampa,
Florida
| – | -$6K | -2 | Closed |
|
|
13
Barclays
London,
United Kingdom
| – | -$1K | -1 | Closed |
|
|
BIM
14
BlackRock Investment Management
Wilmington,
Delaware
| – | -$2K | -1 | Closed |
|
15
UBS Group
Zurich,
Switzerland
| – | -$1K | – | – |
|
ZSAN Hedge Fund Activity: Q2 2016 in Review
11 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q2 2016, worth a combined $7.85M — down 44% from $13.9M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ZSAN and 0 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), adding an estimated $1.29K. The largest seller was Fidelity Investments, cutting an estimated $25.8K.
- 11 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q2 2016, down from 14 in Q1 2016.
- Funds reported $7.85M of Zosano Pharma Corporation stock for Q2 2016, down 44% quarter-over-quarter.
- 0 funds opened new Zosano Pharma Corporation positions in Q2 2016 and 3 closed out, a net change of -3 holders.
- The largest Zosano Pharma Corporation buyer in Q2 2016 was Tower Research Capital (TRC), an estimated $1.29K added.
- The largest Zosano Pharma Corporation seller in Q2 2016 was Fidelity Investments, an estimated $25.8K sold.
Based on aggregated 13F filings for Q2 2016.